
Muhammad Bilal Abid, MD, discusses COVID-19 variant surveillance, monoclonal antibodies, and layered prevention in immunocompromised patients.

Muhammad Bilal Abid, MD, is a clinician-scientist at the University of Texas Health Science Center.

Muhammad Bilal Abid, MD, discusses COVID-19 variant surveillance, monoclonal antibodies, and layered prevention in immunocompromised patients.

Muhammad Bilal Abid, MD, discusses COVID prevention gaps, monoclonal antibodies, and infection risk in immunocompromised patients with CLL.